Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism.

Authors	Michael A Hill, James R Sowers
Journal	Journal of clinical hypertension (Greenwich, Conn.) (J Clin Hypertens (Greenwich)) Vol. 21 Issue 7 Pg. 929-931 (07 2019) ISSN: 1751-7176 [Electronic] United States
PMID	31169977 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Comment)
Chemical References	Mineralocorticoid Receptor Antagonists Spironolactone Amiloride
Topics	Amiloride Humans Hyperaldosteronism Hypertension Mineralocorticoid Receptor Antagonists Spironolactone

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!